Fourth, while our immunohistochemical results suggested that RANKL and PTHrP expression was largely confined to AE1/3-positive OSCC tumor regions, their precise spatial relationship with osteoclast activation remains unclear. This evidence concerns the gene TNFSF11 and neoplasm.